Circulating Contact-Pathway-Activating Microparticles Together with Factors IXa and XIa Induce Spontaneous Clotting in Plasma of Hematology and Cardiologic Patients
Open Access
- 31 January 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e87692
Abstract
Using an in vitro experimental model of immobilized tissue factor-initiated clot growth in platelet-free plasma (thrombodynamics), we observed formation of activator-independent isolated spontaneous clots (SC) throughout the plasma volume in patients with cardiac infarction, acute leukemia, hemolytic anemia, and some other disorders. The aim of this work was to characterize this phenomenon and to identify the mechanisms of SC formation. Tissue factor inhibitor (VIIai) prevented SC in only 2 out of 23 patient plasma samples. Specific inhibitors of factors IXa and XIa were efficient in all 8 cases that we tested. Also, only factors IXa and XIa added to normal donors’ plasma induced SC formations from isolated centers, in a pattern similar to that in patients’ plasma. In contrast, factors VIIa, Va, tissue factor induced uniform plasma clotting. SC disappeared after high-speed centrifugation. However, phospholipid supplementation of centrifuged plasma returned them at least partially in 5 out of 22 patients’ plasmas, indicating some other role of microparticles than providing phospholipid surface. Circulating procoagulant microparticles isolated from plasma directly activated factor XII in buffer and in diluted plasma. Flow cytometry revealed an increase in procoagulant microparticles in patients’ plasmas with SC. Our data suggest that combination of circulating active factors (specifically, factors IXa and XIa) with circulating procoagulant and contact-pathway-activating microparticles is the predominant mechanism causing spontaneous clotting in patient plasma.Keywords
This publication has 31 references indexed in Scilit:
- Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIaJournal of Thrombosis and Haemostasis, 2012
- Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulationThrombosis Research, 2012
- Activated factor XI and tissue factor in aortic stenosisBlood Coagulation & Fibrinolysis, 2011
- Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular eventsThrombosis Research, 2011
- Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular eventsEuropean Journal of Clinical Investigation, 2011
- Task-Oriented Modular Decomposition of Biological Networks: Trigger Mechanism in Blood CoagulationBiophysical Journal, 2010
- Activated human platelets induce factor XIIa-mediated contact activationBiochemical and Biophysical Research Communications, 2010
- Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell diseaseHaematologica, 2009
- IL‐4 and IL‐13 exhibit comparable abilities to reduce pyrogen‐induced expression of procoagulant activity in endothelial cells and monocytesFEBS Letters, 1993
- The effect of spicules obtained from sickle red cells on clotting activityBritish Journal of Haematology, 1984